Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

NorwayBack to Norway

Clinical trials in Lorenskog

69 clinical trials in Lorenskog, Norway across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

NorwayOur site in NorwayKliniske-Studier.no(opens in a new tab)
Lorenskog at a glance
69
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

69 trials in Lorenskog

Open in trial search

Focal segmental glomerulosclerosis

Recruiting
InvestigationalNo placebo
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
  • Sponsor:Boehringer Ingelheim Espana S.A.

Chronic obstructive pulmonary disease

Recruiting
Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited

Cardiovascular disorder+2

Recruiting
Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Acute myocardial infarction

Recruiting
InvestigationalNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH

Chronic obstructive pulmonary disease

Recruiting
Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB

Transitional cell carcinoma metastatic

Recruiting
Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Sepsis

Recruiting
Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Ampicillin Sodium
  • Sponsor:Akershus University Hospital

Renal impairment

Recruiting
Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Iohexol
  • Sponsor:University Of Helsinki

Pancreatic carcinoma

Recruiting
Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Clopidogrel
  • Sponsor:Akershus University Hospital

Oesophageal cancer metastatic+3

Recruiting
Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Daiichi Sankyo Inc.

Plasma cell myeloma

Recruiting
Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Belantamab Mafodotin
  • Sponsor:Glaxosmithkline Research & Development Limited

Crohn's disease

Recruiting
Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Upadacitinib
  • Sponsor:Takeda Development Center Americas Inc.

Other cities in Norway

The busiest research cities in the country

All 54 cities in Norway

Clinical research in Lorenskog

What the registry says about research in the country

01 Oncology Research

Groundbreaking studies focusing on pancreatic ductal cancer, multiple myeloma, and advanced gastric cancers. Research includes innovative combination therapies and personalized treatment approaches.

  • Breast Cancer Treatment Optimization
  • Small-cell Lung Cancer Therapy
  • Prostate Cancer Biomarkers

Trials evaluating novel drug combinations and immunotherapy approaches for better patient outcomes.

02 Neurological Disorders

Clinical investigations examining treatments for Alzheimer's disease and multiple sclerosis. Studies focus on both pharmaceutical interventions and innovative therapeutic approaches.

  • Memory Loss Prevention
  • MS Treatment Enhancement
  • Cognitive Function Studies

Research emphasizes disease-modifying therapies and symptom management strategies.

03 Respiratory Medicine

Studies addressing COPD and severe asthma, including evaluation of new combination therapies and treatment protocols for respiratory conditions.

  • Viral Respiratory Infections
  • Asthma Management
  • Antibiotic Therapy Assessment

Focus on improving lung function and quality of life for patients with chronic respiratory conditions.

04 Gastrointestinal Research

Innovative trials examining treatments for Crohn's Disease and ulcerative colitis, with emphasis on combination therapies and novel therapeutic approaches.

  • Inflammatory Bowel Disease
  • Cholangitis Treatment
  • GI Cancer Therapies

Research aimed at improving disease management and patient outcomes.

Back to NorwayAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

ClinicalTrials.eu

Every clinical trial in Europe, in plain language.

Explore the full ecosystem of clinical research in Europe.

Search trials

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).